Glucose-Lowering Effectiveness of a GLP-1 Agonist vs. an SGLT-2 Inhibitor Allan S. Brett, MD reviewing Lingvay I et al. J Clin Endocrinol Metab 2020 Dec Reduction in glycosylated hemoglobin was greater with a GLP-1 agonist. Glucagon-like peptide-1 (GLP-1) agonists and sodium–glucose cotransporter-2 (SGLT-2) inhibitors have become favored add-on
...more